HIF-1: the Knowns and Unknowns of Hypoxia Sensing
Overview
Authors
Affiliations
Hypoxia-inducible factor-1 (HIF-1) is a transcriptional activator that functions as a master regulator of cellular and systemic oxygen homeostasis. It consists of two constitutively produced subunits: HIF-1alpha and HIF-1beta. Under normoxic conditions HIF-1alpha undergoes hydroxylation at specific prolyl residues which leads to an immediate ubiquitination and subsequent proteasomal degradation of the alpha subunit. Additionally, hydroxylation of an asparaginyl residue blocks the transcriptional activity of HIF-1 due to inhibition of its interaction with co-activators. In contrast, under hypoxic conditions, abolition of prolyl hydroxylation results in HIF-1alpha stabilization, whereas the lack of asparaginyl hydroxylation allows the transcriptional activity. Additionally, the transcriptional activity may be modulated by phosphorylation or redox modification of HIF-1. Despite its name, HIF-1 is induced not only in response to reduced oxygen availability but also by other stimulants, such as nitric oxide, various growth factors, or direct inhibitors of prolyl and asparaginyl hydroxylases. Therefore, it seems to be a crucial transcription factor elicited by a wide range of stresses such as impaired oxygenation, inflammation, energy deprivation, or intensive proliferation. However, the mechanisms of normoxic activation, as well as of oxygen sensing, are not yet fully known. Further understanding of the processes that control HIF-1 activity will be crucial for the development of new diagnostic and therapeutic strategies.
Adipose Tissue Hypoxia in Obesity: Clinical Reappraisal of Hypoxia Hypothesis.
Engin A Adv Exp Med Biol. 2024; 1460:329-356.
PMID: 39287857 DOI: 10.1007/978-3-031-63657-8_11.
The relationship between hypoxia and Alzheimer's disease: an updated review.
Tao B, Gong W, Xu C, Ma Z, Mei J, Chen M Front Aging Neurosci. 2024; 16:1402774.
PMID: 39086755 PMC: 11288848. DOI: 10.3389/fnagi.2024.1402774.
van den Bovenkamp K, van der Vegt B, Halmos G, Slagter-Menkema L, Langendijk J, van Dijk B Eur Arch Otorhinolaryngol. 2023; 280(8):3801-3809.
PMID: 37029804 PMC: 10313532. DOI: 10.1007/s00405-023-07951-9.
Sayed T, Maayah Z, Zeidan H, Agouni A, Korashy H Cell Mol Biol Lett. 2022; 27(1):103.
PMID: 36418969 PMC: 9682773. DOI: 10.1186/s11658-022-00397-7.
Hou J, Wen X, Long P, Xiong S, Liu H, Cai L Front Cardiovasc Med. 2022; 9:886300.
PMID: 36186970 PMC: 9515308. DOI: 10.3389/fcvm.2022.886300.